Skip to main content
Photo of Reena Sandhu

Reena Sandhu

Contact Information

Peer Reviewed Publications

Haber, Lynne T; Sandhu, Reena; Li-Muller, Angela; Mohapatra, Asish; Petrovic, Sanya; Meek, M E Bette 2016. Framework for human health risk assessment of non-cancer effects resulting from short-duration and intermittent exposures to chemicals. Journal of applied toxicology : JAT, 36 9, 1077-89

Hayes, Eileen P; Jolly, Robert A; Faria, Ellen C; Barle, Ester Lovsin; Bercu, Joel P; Molnar, Lance R; Naumann, Bruce D; Olson, Michael J; Pecquet, Alison M; Sandhu, Reena; Shipp, Bryan K; Sussman, Robert G; Weideman, Patricia A 2016. A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations. Regulatory toxicology and pharmacology : RTP, 79 Suppl 1 , S39-47

Reichard, John F; Maier, M Andrew; Naumann, Bruce D; Pecquet, Alison M; Pfister, Thomas; Sandhu, Reena; Sargent, Edward V; Streeter, Anthony J; Weideman, Patricia A 2016. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals. Regulatory toxicology and pharmacology : RTP, 79 Suppl 1 , S67-78

Sargent, Edward V; Flueckiger, Andreas; Barle, Ester Lovsin; Luo, Wendy; Molnar, Lance R; Sandhu, Reena; Weideman, Patricia A 2016. The regulatory framework for preventing cross-contamination of pharmaceutical products: History and considerations for the future. Regulatory toxicology and pharmacology : RTP, 79 Suppl 1 , S3-S10

Sandhu, Reena; Teichert-Kuliszewska, Krystyna; Nag, Sukriti; Proteau, Gerald; Robb, Malcolm J; Campbell, Andrew I M; Kuliszewski, Michael A; Kutryk, Michael J B; Stewart, Duncan J 2004. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovascular research, 64 1, 115-24

Wicks, David; Wong, Lawrence T; Sandhu, Reena; Stewart, Richard K; Biro, George P 2003. The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs. Artificial cells, blood substitutes, and immobilization biotechnology, 31 1, 1-17

Kingma, J G; Sandhu, Reena; Hamelin, N D; Gendron, D; Trudel, Y; Bosa, M; Stewart, R; Fargey, M B; Biro, G P 2002. The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs. Artificial cells, blood substitutes, and immobilization biotechnology, 30 2, 137-54

Campbell, A I; Zhao, Y; Sandhu, R; Stewart, D J 2001. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation, 104 18, 2242-8

Kuliszewski, Michael A; Kutryk, Michael JB; Sandhu, Reena; Fitchett, David; Stewart, Duncan J 2000. DNA integrity and transgene expression after passage through the NOGA needle catheter used for therapeutic myocardial angiogenesis. International journal of cardiovascular interventions, 3 3, 167-172

Sandhu, R; Diaz, R J; Mao, G D; Wilson, G J 1997. Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation, 96 3, 984-95

Sandhu, R; Thomas, U; Diaz, R J; Wilson, G J 1996. Effect of ischemic preconditioning of the myocardium on cAMP. Circulation research, 78 1, 137-47

Sandhu, R; Diaz, R J; Wilson, G J 1993. Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovascular research, 27 4, 602-7

Feindel, C M; Sandhu, R; Cruz, J; Wilson, G J 1992. Effect of delay in retroperfusion therapy on infarct size reduction. The Annals of thoracic surgery, 54 6, 1120-5

Ropchan, G. V., Feindel, C. M., Wilson, G. J., Boylen, P., and R. Sandhu 1992. Salvage of ischemic myocardium by non-synchronized coronary sinus retroperfusion in the pig. Journal of Thoracic and Cardiovascular Surgery, 104 , 619

Feindel, C. M., Cruz, J., Sandhu, R., and G. J. Wilson 1991. The effectiveness of various modes of non-synchronized retrovenous therapy in salvage of ischemic myocardium in the pig. Canadian Journal of Cardiology, 7 , 357-365